Skip to main content

Banc of America Downgrades Sigma-Aldrich in Wake of Advanced Separations Buy

NEW YORK (GenomeWeb News) – Banc of America Securities has downgraded Sigma-Aldrich from “buy” to “neutral.”
On Monday, Sigma said that it had acquired Advanced Separations, a developer of products used in chiral chromatography, for an undisclosed amount.
Advanced Separations, based in Whippany, NJ, has annual revenue of $2 million. Sigma said the acquisition will not have a material impact on sales this year, but will be neutral to earnings in 2006 and should help it meet its growth goals over the next several years.
As of mid-day Wednesday, Sigma’s shares were down 2.9 percent at $74.94.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.